Annias Immunotherapeutics Inc. (Annias)

Oncology Corporate Profile

HQ Location

3 Sedgewood Road
Chapel Hill, NC 27514

Company Description

Annias Immunotherapeutics, Inc. is a clinical stage immuno-oncology company focused on the development of novel immunotherapeutic approaches to the treatment of cancers that containing Cytomegalovirus (CMV). The company's approach is based on a patented and proprietary immunotherapeutic platform, discovered at Duke University, which harnesses the body's immune system to recognize, attack and destroy tumor cells containing CMV. CMV is over-expressed in a variety of human cancers including significant and homogeneous expression in almost all glioblastoma, but not in normal brain tissue.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
PEPIDH1Mdendritic cell vaccineGlioblastoma Multiforme (GBM)I


Recent News Headlines

There are no news items to display